Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study

Radiotherapy and Oncology

Volumn 77, Issue 1, 2005, Pages 5-10

  De Ruysscher, Dirk ^a,b,e   Wanders, Stofferinus ^a   Minken, Andre ^a   Lumens, Aniek ^a   Schiffelers, Jacqueline ^a   Stultiens, Cissie ^a   Halders, Serve ^c   Boersma, Liesbeth ^a   Van Baardwijk, Angela ^a   Verschueren, Tom ^a   Hochstenbag, Monique ^c   Snoep, Gabriel ^c   Wouters, Brad ^a,b   Nijsten, Sebastiaan ^a   Bentzen, Søren M ^d   Van Kroonenburgh, Marinus ^c   Öllers, Michel ^a   Lambin, Philippe ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRO CLINIC   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e GROW   (Netherlands)

Author keywords

Dose escalation; NSCLC; PET CT; Planning; Radiotherapy; Toxicity

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; ESOPHAGUS DISEASE; GASTROINTESTINAL TOXICITY; HUMAN; LUNG NON SMALL CELL CANCER; MATHEMATICAL COMPUTING; NEUROTOXICITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; RADIATION PNEUMONIA; SIMULATION; SIMULATOR; SPINAL CORD DISEASE; TREATMENT PLANNING;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGITIS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 27144513765     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.06.014     Document Type: Conference Paper

References (20)

1. G. Antoch, J. Stattaus, and A.T. Nemat Non-small cell lung cancer: dual-modality PET/CT in preoperative staging Radiology 229 2003 526 533
2. S.M. Bentzen, and S.L. Tucker Quantifying the steepness of dose-response curves Int J Radiat Biol 71 1997 531 542
3. J. Bradley, W.L. Thorstad, and S. Mutic Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 78 86
4. C.B. Caldwell, K. Mah, C.E. Danjoux, and P.E.T. Can provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET Int J Radiat Oncol Biol Phys 55 2003 1381 1393
5. I.F. Ciernik, E. Ditzendorf, and B.G. Baumert Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int J Radiat Oncol Biol Phys 57 2003 853 863
6. W. Curran, C. Scott, and C. Langer Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III nsclc: RTOG 9410 [Abstract] Proc ASCO 9410 2003 2499
7. De Ruysscher D, Wanders S, van Haren E, et al. Selective mediastinal node irradiation on basis of the FDG-PET scan in patients with non-small cell lung cancer: results of a prospective clinical study. Int J Radiat Oncol Biol Phys 2005; In Press.
8. K. Furuse, M. Fukuoka, and M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
9. G.W. Goerres, C. Burger, and E. Kamel : Respiration-induced attenuation artifact at PET/CT: technical considerations Radiology 226 2003 906 910
10. M.V. Graham, J.A. Purdy, and B.E. Enami Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 1999 323 329
11. ICRU Report 50. Prescribing, Recording, and reporting Photon Beam Therapy. International Commission on Radiation Units and Measurements. 1993.
12. S.L. Kwa, J.V. Lebesque, and J.C. Theuws Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data from 540 patients Int J Radiat Oncol Biol Phys 42 1998 1 9
13. D. Lardinois, W. Weder, and T. Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500 2507
14. M. Martel, R. Ten Haken, and M. Hazuka Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients Lung Cancer 24 1999 31 37
15. T. Naruke, K. Suemasu, and S. Ishiwaka Lymph node mapping and curability at various levels of metastasis in resected lung cancer J Thorac Cardiovasc Surg 76 1978 832 837
16. M.I. Saunders, S. Dische, and A. Barrett Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multi-center trial Radiother Oncol 52 1999 137 148
17. W. Sause, P. Kolesar, and S. Taylor Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group Eastern Cooperative Oncology Group, and Southwest Oncology Group Chest 117 2000 358 364
18. S. Senan, D. De Ruysscher, and P.R. Giraud Literature-based recommendations for treatment planning and execution for high-precision radiotherapy in lung cancer Radiother Oncol 71 2004 139 146
19. 18FDG-PET-CT planning in patients with clinical CT stage N2/N3 M0 non-small cell lung cancer (NSCLC): A modelling study Int J Radiation Oncol Biol Phys 61 2005 648 654
20. J.F. Vansteenkiste, S.G. Stroobants, and P.J. Dupont FDG-PET scan in potentially operable non-small cell lung cancer: Do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? Eur J Nucl Med 25 1998 1495 1501